Subsequently, we constructed a predictive model (pan-cancer STMN2.SIG) for immunotherapy response by leveraging diverse ML techniques and integrating comprehensive scRNA-seq and bulk transcriptomic data, thereby enhancing prediction accuracy and showcasing innovation. Here, STMN2 is linked to cancer.